2 result(s) for
|PI Name||Protocol #||Title|
|Ronan Swords||STUDY00018059||A Phase I/II, open-label, multi-center study evaluating the safety and efficacy of Ruxolitinib and CPX-351 in combination for the treatment of Advanced Phase Myeloproliferative Neoplasms.|
|Laura Newell||STUDY00018809||A Phase 1 Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 (Daunorubicin and Cytarabine) Liposome for Injection Treatment in Adult Patients with Hematologic Malignancies|
You may also qualify for Phase 1 Program trials.
For more information: